Clinical Trial Update: Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update on low-dose iron supplementation in non-anemic iron-deficient women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-anemic Iron Deficiency

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Non-anemic Iron Deficiency | Phase 2, Phase 3 | Status: COMPLETED